Skip to main content
SRTA
NASDAQ Life Sciences

Strata Bolsters Medical Offerings with Ohio Valley Perfusion Acquisition

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
7
Price
$4.952
Mkt Cap
$433.962M
52W Low
$2.57
52W High
$6.02
Market data snapshot near publication time

summarizeSummary

Strata Critical Medical, Inc. has announced the acquisition of Ohio Valley Perfusion Associates. This strategic move expands Strata's service capabilities within the critical care and medical logistics sector, aligning with the company's previously reported strategic shift and strong 2025 financial performance. The acquisition is expected to enhance Strata's market position and contribute to its growth trajectory. Traders will be watching for further details on the financial terms of the deal and its anticipated impact on future earnings.

At the time of this announcement, SRTA was trading at $4.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $434M. The 52-week trading range was $2.57 to $6.02. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed SRTA - Latest Insights

SRTA
May 06, 2026, 11:53 AM EDT
Filing Type: 10-Q
Importance Score:
8
SRTA
May 06, 2026, 7:09 AM EDT
Filing Type: 8-K
Importance Score:
7
SRTA
Apr 30, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
SRTA
Apr 16, 2026, 5:31 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
SRTA
Apr 14, 2026, 8:54 AM EDT
Filing Type: DEF 14A
Importance Score:
8
SRTA
Apr 08, 2026, 5:03 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
SRTA
Apr 07, 2026, 5:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
SRTA
Mar 03, 2026, 11:52 AM EST
Filing Type: 10-K
Importance Score:
8
SRTA
Mar 03, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
SRTA
Feb 05, 2026, 9:09 AM EST
Filing Type: 8-K
Importance Score:
8